Bolze et al. assessed 34 cases of chemoresistance and identified activation of IFNγ in mono-chemoresistant choriocarcinoma and inhibition of IL2 and TNF in poly-chemoresistant choriocarcinoma [70]. This evidence concerns the gene IL2 and choriocarcinoma.